Benjamin G Trist,Sian Genoud,Stéphane Roudeau,Alexander Rookyard,Amr Abdeen,Veronica Cottam,Dominic J Hare,Melanie White,Jens Altvater,Jennifer A Fifita,Alison Hogan,Natalie Grima,Ian P Blair,Kai Kysenius,Peter J Crouch,Asuncion Carmona,Yann Rufin,Stéphane Claverol,Stijn Van Malderen,Gerald Falkenberg,David J Paterson,Bradley Smith,Claire Troakes,Caroline Vance,Christopher E Shaw,Safa Al-Sarraj,Stuart Cordwell,Glenda Halliday,Richard Ortega,Kay L Double

Abstract:Abstract Aberrant self-assembly and toxicity of wild-type and mutant superoxide dismutase 1 (SOD1) has been widely examined in silico, in vitro and in transgenic animal models of amyotrophic lateral sclerosis. Detailed examination of the protein in disease-affected tissues from amyotrophic lateral sclerosis patients, however, remains scarce. We used histological, biochemical and analytical techniques to profile alterations to SOD1 protein deposition, subcellular localization, maturation and post-translational modification in post-mortem spinal cord tissues from amyotrophic lateral sclerosis cases and controls. Tissues were dissected into ventral and dorsal spinal cord grey matter to assess the specificity of alterations within regions of motor neuron degeneration. We provide evidence of the mislocalization and accumulation of structurally disordered, immature SOD1 protein conformers in spinal cord motor neurons of SOD1-linked and non-SOD1-linked familial amyotrophic lateral sclerosis cases, and sporadic amyotrophic lateral sclerosis cases, compared with control motor neurons. These changes were collectively associated with instability and mismetallation of enzymatically active SOD1 dimers, as well as alterations to SOD1 post-translational modifications and molecular chaperones governing SOD1 maturation. Atypical changes to SOD1 protein were largely restricted to regions of neurodegeneration in amyotrophic lateral sclerosis cases, and clearly differentiated all forms of amyotrophic lateral sclerosis from controls. Substantial heterogeneity in the presence of these changes was also observed between amyotrophic lateral sclerosis cases. Our data demonstrate that varying forms of SOD1 proteinopathy are a common feature of all forms of amyotrophic lateral sclerosis, and support the presence of one or more convergent biochemical pathways leading to SOD1 proteinopathy in amyotrophic lateral sclerosis. Most of these alterations are specific to regions of neurodegeneration, and may therefore constitute valid targets for therapeutic development.

Detection the mutated protein aggregation and mitochondrial function in fibroblasts from amyotrophic lateral sclerosis patients with SOD1 gene mutations

Clinical Features and Cu/Zn Superoxide Dismutase Gene Mutations in Two Mainland Chinese Families with Amyotrophic Lateral Sclerosis

Identification and Functional Analysis of Novel Mutations in the SOD1 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.

Altered SOD1 maturation and post-translational modification in amyotrophic lateral sclerosis spinal cord

Alteration of Mitochondrial Integrity as Upstream Event in the Pathophysiology of SOD1-ALS

SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells

High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation

Induced pluripotent stem cell-derived motor neurons from amyotrophic lateral sclerosis (ALS) patients carrying different superoxide dismutase 1 mutations recapitulate pathological features of ALS

Implications of ALS-Associated Mutations on Biochemical and Biophysical Features of hSOD1 and Aggregation Formation

[Screening of Mutations in SOD1 Gene and Analysis of Genotype-Phenotype Correlation in Chinese Patients with Amyotrophic Lateral Sclerosis].

Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS

Hyperactive intracellular calcium signaling associated with localized mitochondrial defects in skeletal muscle of an animal model of amyotrophic lateral sclerosis

Amyloid fibril structures and ferroptosis activation induced by ALS-causing SOD1 mutations

Increased Mitochondrial Superoxide Production in the Skeletal Muscle Derived from a Double-Transgenic Mouse Model of Amyotrophic Lateral Sclerosis

Altered Mitochondrial Superoxide Production In Skeletal Muscle Of An Als Mouse Model During The Disease Progression

Comprehensive in silico analysis and molecular dynamics of the superoxide dismutase 1 (SOD1) variants related to amyotrophic lateral sclerosis

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

The G41D mutation in SOD1-related amyotrophic lateral sclerosis exhibits phenotypic heterogeneity among individuals: A case report and literature review

Missense Mutations of Codon 116 in the SOD1 Gene Cause Rapid Progressive Familial ALS and Predict Short Viability With PMA Phenotype

Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy

Association Between Superoxide Dismutase 1 Mutations and Clinical Phenotypes in Chinese Patients with Familial Amyotrophic Lateral Sclerosis